View this email in your browser
Click here to access the Telegraft Archive
Volume 27 | Issue 1
February 2020
Featured in this Issue
ISCT Leadership Spotlight
Janet Macpherson, PhD (Australia)
2020 ISCT Elections
Meet your Candidates & Vote before March 9
ISCT 2020 Paris
Accelerating Adoption – Proof of Concept to Standard of Care
Top 3 Reasons to Attend ISCT 2020
ISCT Commercialization Signature Series
Clinical Breakthroughs: Transforming the Standard of Care

Member News
News & Press Releases
ISCT Community Calendar
ISCT Career Center

ISCT Webinars Program
ISCT Volunteer Center
Regular Updates
Cytotherapy® Corner
(Bone Marrow Transplantation, CGT, MSCs)
ISCT Early Stage Professionals Series
(ESP Guest Blogger, ISCT 2020 Paris)
ISCT Lab Practices Committee Snapshot
(Development of CAR-T Clinical Product)
FACT Report 
(Immune Effector Cell Therapy Webinar Series, Accreditation Workshop + Quality Boot Camp at ISCT 2020, Quality Manager Resiliency Survey)
PACT Update
(Retroviral Transduction, T Cells
Global Regulatory Surveillance
Australia and New Zealand Watchdog
(TGA Updates)
Europe Watchdog®
(European Pharmacopoeia programme update, EMA consultations, WHO Expert Committee on Biological Standardization meeting)
North America Watchdog®
(FDA & Health Canada Guidance Documents)
From the Editors:
The Importance of the “I” in ISCT   
by Nancy H. Collins, PhD

In this month’s editorial Nancy Collins, Telegraft Senior Editor introduces the new Editorial Board members and several initiatives to increase the Telegraft's coverage of international issues in cell and gene therapy in volume 27 in 2020.

From the President's Desk
by John Rasko, AO, BSc(Med), MBBS(Hons), PhD, MAICD, FFSc(RCPA), FRCPA, FRACP, FAHMS

Anyone might be forgiven for observing that the world seems unusually unstable these days. Turmoil seems to be swirling around every corner of the globe. There is political instability and civil unrest along with challenges to scientific research in places such as Syria, Bolivia, Sudan, Iran, Chile, Ecuador, Lebanon, Venezuela, Hong Kong and Catalonia (Nature 576, 382, December 2019). There is the conclusion of the fraught Brexit process and the third impeachment in history. There is a new coronavirus of potentially pandemic proportions and devastating climate change affecting so many countries including the bushfires affecting my beloved Australia. Young people in our societies are confused for their future and often feeling unbalanced due to this uncertainty. How can ISCT help to support individuals and provide, in its own small way, some reassurance? 
ISCT Leadership Spotlight: Janet Macpherson, PhD (Australia)
Since attending her first ISCT Annual Meeting in 2001, Janet Macpherson has held several leadership roles within ISCT and continues to be an integral member of the ANZ Regional Committee, Telegraft Editorial Board, and Mentor to ESPs. Janet has led gene therapy product management, process development and GMP manufacturing, and has managed clinical trials submissions and reporting at J&J. She has set up an entirely new facility for cell and gene therapy at the Royal Prince Alfred Hospital in Sydney and is currently a Cell & Gene Therapy Specialist for GE Healthcare Life Sciences. Learn about Janet's career journey and what she enjoys most about working in the field of cell and gene therapy!
Oscar Lee & Janet Macpherson chairing Plenary Session 2 – Complex Cellular Structures: Realising The Regenerative Potential of Cells at ISCT 2019
The ISCT 2019 Melbourne Annual Meeting Organizing Committee stopped for a quick
group selfie on stage at the Gala! 
2020 ISCT Elections - Meet your Candidates and Vote Now!

Your vote is your voice! This is your opportunity to elect the future leaders of ISCT. Make your vote count.

Voting is open February 24 - March 9.

View the full Candidate Profiles and cast your votes on the ISCT website
ISCT Europe Regional Executive Committee: Challenges for 2020
by Joan Garcia, MD, PhD

Meet the ISCT Europe Regional Executive Committee! Joan Garcia, MD, PhD, ISCT Europe Regional Vice-President reflects on the activities and projects the committee will take on this year. Learn about the upcoming educational opportunities for ISCT European members and other opportunities to get involved.  
Dear Colleagues,

As we put the finishing touches on the ISCT 2020 Paris program, we pause to reflect on what makes this program so unique from all of the educational options you have to choose from. As scientists and clinicians working in this field, we are proud to work with a leading global organization dedicated to ensuring the development of CGT. There are many great reasons to come to Paris, but we think these are the top 3 reasons that you should make ISCT 2020 your CGT conference of choice in 2020!

1. A curated scientific program, built by a team of leading CGT experts

2. Your registration fees are reinvested to advance the field

3. A unique, holistic representation of the translational pathway

Christian Chabannon, MD, PhD
ISCT 2020 Paris Co-Chair
Institut Paoli-Calmettes, FRA 
Rachele Ciccocioppo, MD
ISCT 2020 Paris Co-Chair
University of Verona, ITA
Ivan Martin, PhD
ISCT 2020 Paris Co-Chair 
University Hospital Basel, CHE
ISCT 2020 Program
With the goal of Accelerating Cell & Gene Therapy Adoption – Proof of Concept to Standard of Care, ISCT 2020 Paris will bring you 4 full days of highly curated scientific programming that cuts across the key challenges, successes and prominent questions facing the CGT community today. 
Overcoming Regulatory, Quality and Validation Challenges in CGT Manufacturing 
ISCT 2020 Quality and Operations Track and pre-conference events will address regional nuances and global implications that are critical to the production and delivery of cell and gene therapies for patients. 
Advancing Cell and Gene Therapy from Commercialization to Industrialization
10 dedicated educational sessions will present critical Strategies for Commercialization and offer unparalleled insight from industry leaders. 
Late Breaking Abstract Submission
Late Breaking Abstract Submission Opens March 2-8, 2020
The ISCT Late Breaking Abstract Submission Period provides investigators with recently acquired, novel, and ground-breaking research, not previously available for submission to ISCT 2020 Paris, the opportunity for Oral or Poster Presentation at the ISCT Annual Meeting.
ISCT 2020 Guest Blogger Applications
The ISCT ESP Committee is Recruiting 3 Guest Bloggers for
ISCT 2020 Paris 

Are you a social-media savvy Early Stage Professional (ESP) and science communicator? Think you have what it takes to disseminate content live from ISCT 2020? Apply by March 5th for an opportunity to network with leading cell and gene therapy experts and earn a free conference registration.
Plan Your Attendance

Discounted registration rates available until February 25th 

Meeting Justification Tools - Let's get you to Paris!

Secure your discounted accommodation before it's too late!



15% group discount available for 5+ registrations

ISCT has created tools you can customize to help gain your supervisor/employer's support to attend the meeting. 

ISCT has secured preferred rates at two Paris hotels, both located steps away from the convention center.
There are limited rooms available so book now!

From L-R: Julie Allickson (Wake Forest Institute for Regenerative Medicine),
Camillo Ricordi (University of Miami), Megan Liles (Precision Medicine),
Tony Ting (Athersys), Kurt Gunter (Cell Medica)
ISCT 3rd Annual Commercialization Signature Series
Clinical Breakthroughs: Transforming the Standard of Care 

by Madeline St. Onge

More than 40 members of the ISCT industry community gathered in Miami on January 21 for the 3rd annual Commercialization Signature Series. This year’s theme, Clinical Breakthroughs: Transforming the Standard of Care featured presenters with unique perspectives from across the translation pipeline sharing strategies for achieving clinical success. 
From the Blogosphere and Twitterverse: COVID-19
by Conrad Russell Y. Cruz, MD, PhD

Dr. Cruz describes the compelling history of the novel coronavirus (COVID-19) 2019 outbreak in China and how social media has been a vehicle for the dissemination of both accurate and inaccurate medical information. He outlines how medical experts counter inaccurate information using social media platforms and provides links to expert opinions on various aspects of the outbreak. This is an important lesson for medical professionals, such as the members of ISCT, who should be aware of the strengths and dangers of information spread through social media. 
New and Improved ISCT Career Center - Connecting Talent with Opportunity

ISCT has launched a new and improved career center!

Featuring enhanced functionality and advanced search options for job seekers and employers.

Offering companies access to a resume bank to find candidates and resources for job seekers to assist with career development.

Visit the 
ISCT Career Center to find out more. Subscribe to job alerts and stay informed of available postings within your desired position.

Q&A with Alex’s Lemonade Stand Foundation (ALSF)
by Nicole Bonan

Readers of The Telegraft are probably well-versed with the research side of cancer. However, we might not be so aware of the goings-on at cancer foundations. In the next few issues of The Telegraft, we’ll be introducing a series of interviews with different cancer foundations to learn a little bit more about what they do and where they see the field of cancer research heading. This issue features an interview with Alex's Lemonade Stand Foundation (ALSF). 
ISCT Webinars - New Recording Available
Gene Therapy and Gene Editing for Hemoglobinopathies: The Basics, The Present, and The Future
Sponsored by ISCT
Organized by the ISCT Immuno & Gene Therapy Committee
Telegraft Editorial Board

Nancy H. Collins, PhD
Russell Cruz, MD
Satyam Arora, MD
Rounak Dubey, MBBS, MD

Shyam Bhakta, MD, MBA, FACC, FAHA, FSCAI
Ashley Krull, BSc, PhD
Anne Lamontagne, MSc
Janet Macpherson, PhD 
Lynn O'Donnell, PhD 
Michele Sugrue, MT 
Wouter Van't Hof, PhD
Joaquim Vives Armengol
Suite 325 - 744 West Hastings Street Vancouver, BC V6C 1A5
+1 (604) 874-4366 | 

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.